Wed, 27 Aug 2008 09:28:25 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/neurology/album_art_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Neurology no PeerView Press In this CME/CE activity, experts in the management of dementia present recent data on the diagnosis and treatment of Alzheimer's disease and vascular dementia. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the management of dementia present recent data on the diagnosis and treatment of Alzheimer's disease and vascular dementia. http://podcast.peerviewpress.com/neurology/PA04467FCr379.mp3 http://podcast.peerviewpress.com/neurology/PA04467FCCMEinfo.pdf Wed, 06 Aug 2008 14:56:47 -0400 Science no 00:00:00 memantine, rivastigmine, galantamine, donepezil, cholinesterase inhibitors, NMDA-receptor antagonist, Alzheimer's disease, vascular dementia, mild cognitive impairment, MRI PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA04467FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA04467FCr379.mp3 Wed, 06 Aug 2008 14:54:47 -0400 Science no 00:58:37 memantine, rivastigmine, galantamine, donepezil, cholinesterase inhibitors, NMDA-receptor antagonist, Alzheimer's disease, vascular dementia, mild cognitive impairment, MRI PeerView Press In this CME/CE activity, experts in the management of FMS discuss diagnosis and management of this complex disorder. Strategies for collaboration between multiple specialties in the treatment of patients with FMS are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the management of FMS discuss diagnosis and management of this complex disorder. Strategies for collaboration between multiple specialties in the treatment of patients with FMS are also highlighted. http://podcast.peerviewpress.com/neurology/PA04412FCe016.mp3 http://podcast.peerviewpress.com/neurology/PA04412FCe016.mp3 Fri, 18 Jul 2008 10:40:08 -0400 Science no 01:05:51 Tender points, duloxetine, pregabalin, gabapentin, milnacipran, pramipexole, exercise, pain, cognitive-behavioral therapy, EULAR, ACR, depression, sleep PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA04421FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA04412FCCMEinfo.pdf Fri, 18 Jul 2008 10:39:08 -0400 Science no 00:00:00 Tender points, duloxetine, pregabalin, gabapentin, milnacipran, pramipexole, exercise, pain, cognitive-behavioral therapy, EULAR, ACR, depression, sleep PeerView Press In this CME activity, experts in the treatment of multiple sclerosis consider recent studies on the early treatment of MS. Long-term data on safety and efficacy and head-to-head comparisons of available therapies are presented. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of multiple sclerosis consider recent studies on the early treatment of MS. Long-term data on safety and efficacy and head-to-head comparisons of available therapies are presented. http://podcast.peerviewpress.com/neurology/PA04011FCr378.mp3 http://podcast.peerviewpress.com/neurology/PA04011FCr378.mp3 Thu, 03 Jul 2008 09:25:25 -0400 Science no 00:29:52 MS, interferon, glatiramer acetate, mitoxantrone, natalizumab, PRISMS, CHAMPS, CHAMPIONS, ETOMS, REFLEX, BENEFIT, PRECISE PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA04011FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA04011FCCMEinfo.pdf Thu, 03 Jul 2008 09:25:22 -0400 Science no 00:00:00 MS, interferon, glatiramer acetate, mitoxantrone, natalizumab, PRISMS, CHAMPS, CHAMPIONS, ETOMS, REFLEX, BENEFIT, PRECISE PeerView Press In this CME/CE activity, experts in the treatment of epilepsy discuss the management of this condition in women. Recent data on bone and reproductive health in women with epilepsy are reviewed. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the treatment of epilepsy discuss the management of this condition in women. Recent data on bone and reproductive health in women with epilepsy are reviewed. http://podcast.peerviewpress.com/neurology/PA03785FCr374.mp3 http://podcast.peerviewpress.com/neurology/PA03785FCr374.mp3 Fri, 18 Apr 2008 14:52:06 -0400 Science no 00:28:18 Phenytoin, vitamin D, DEXA, calcium, valproate, benzodiazepines, zonisamide, ethosuximide, lamotrigine, pregabalin, gabapentin, carbamazepine, topiramate PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03785FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03785FCCMEinfo.pdf Fri, 18 Apr 2008 14:52:03 -0400 Science no 00:00:00 Phenytoin, vitamin D, DEXA, calcium, valproate, benzodiazepines, zonisamide, ethosuximide, lamotrigine, pregabalin, gabapentin, carbamazepine, topiramate PeerView Press In this activity, experts in the treatment of multiple sclerosis present the most current safety data associated with the use of broad-spectrum immunomodulatory/immunosuppressive agents and monoclonal antibodies in multiple sclerosis. In addition, the investigational status of oral therapies in MS is clarified. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of multiple sclerosis present the most current safety data associated with the use of broad-spectrum immunomodulatory/immunosuppressive agents and monoclonal antibodies in multiple sclerosis. In addition, the investigational status of oral therapies in MS is clarified. http://podcast.peerviewpress.com/neurology/PA04137FCr359.mp3 http://podcast.peerviewpress.com/neurology/PA04137FCr359.mp3 Thu, 24 Jan 2008 11:44:01 -0500 Science no 00:30:48 Multiple sclerosis, Interferon beta, Glatiramer acetate, Mitoxantrone, Cyclophosphamide, Azathioprine, Mycophenolate mofetil, Natalizumab, Rituximab, Daclizumab, Alemtuzumab, Cladribine, Fingolimod, Teriflunomide, Laquinimod, BG-12, Dimethyl fumarate PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA04137FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA04137FCCMEinfo.pdf Thu, 24 Jan 2008 11:43:01 -0500 Science no 00:00:00 Multiple sclerosis, Interferon beta, Glatiramer acetate, Mitoxantrone, Cyclophosphamide, Azathioprine, Mycophenolate mofetil, Natalizumab, Rituximab, Daclizumab, Alemtuzumab, Cladribine, Fingolimod, Teriflunomide, Laquinimod, BG-12, Dimethyl fumarate PeerView Press In this activity, experts in the treatment of multiple sclerosis discuss data presented at the 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2007) concerning the use of the monoclonal antibodies natalizumab, rituximab, daclizumab, and alemtuzumab in this disorder. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of multiple sclerosis discuss data presented at the 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2007) concerning the use of the monoclonal antibodies natalizumab, rituximab, daclizumab, and alemtuzumab in this disorder. http://podcast.peerviewpress.com/neurology/PA03646FC3s430.mp3 http://podcast.peerviewpress.com/neurology/PA03646FC3s430.mp3 Fri, 11 Jan 2008 17:31:01 -0500 Science no 00:25:58 Multiple sclerosis,Alemtuzumab,Natalizumab,Rituximab,Daclizumab,Monoclonal antibody,T cell,B cell,Epstein-Barr virus (EBV), Neuromyelitis optica,European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03646FC3CMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03646FC3CMEinfo.pdf Fri, 11 Jan 2008 17:30:57 -0500 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Neurology PeerView Press In this activity, an expert in the management of multiple sclerosis (MS) discusses data supporting the early use of interferon-beta and describes the current clinical development of targeted agents and oral compounds in this condition. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the management of multiple sclerosis (MS) discusses data supporting the early use of interferon-beta and describes the current clinical development of targeted agents and oral compounds in this condition. http://podcast.peerviewpress.com/neurology/PA03748FCn168.mp3 http://podcast.peerviewpress.com/neurology/PA03748FCn168.mp3 Wed, 14 Nov 2007 15:50:49 -0500 Science no 00:22:29 Multiple sclerosis, Interferon-beta, Glatiramer acetate, Natalizumab, Rituximab, Daclizumab, Alemtuzumab, Cladribine, Fingolimod, Teriflunomide, Laquinimod, BG00012 PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03748FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03748FCCMEinfo.pdf Wed, 14 Nov 2007 15:50:46 -0500 Science no 00:00:00 Multiple sclerosis, Interferon-beta, Glatiramer acetate, Natalizumab, Rituximab, Daclizumab, Alemtuzumab, Cladribine, Fingolimod, Teriflunomide, Laquinimod, BG00012 PeerView Press In this activity, expert neurologists discuss the guidelines for an evidence-based use of broad-spectrum immunomodulatory therapies in multiple sclerosis and the rationales for integrating targeted therapies into the management of the disease. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, expert neurologists discuss the guidelines for an evidence-based use of broad-spectrum immunomodulatory therapies in multiple sclerosis and the rationales for integrating targeted therapies into the management of the disease. http://podcast.peerviewpress.com/neurology/PA03646FC2r341.mp3 http://podcast.peerviewpress.com/neurology/PA03646FC2r341.mp3 Thu, 25 Oct 2007 16:17:56 -0400 Science no 00:30:34 Alemtuzumab, Antibody, antichimeric, Antibody, monoclonal, Antibody, neutralizing, B cell, CD20, CD56, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin 2 (IL-2), Mitoxantrone, Multiple sclerosis PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03646FC2CMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03646FC2CMEinfo.pdf Thu, 25 Oct 2007 16:17:51 -0400 Science no 00:00:00 Alemtuzumab, Antibody, antichimeric, Antibody, monoclonal, Antibody, neutralizing, B cell, CD20, CD56, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin 2 (IL-2), Mitoxantrone, Multiple sclerosis PeerView Press In this activity, expert neurologists discuss the rationales for integrating targeted therapies into the management of multiple sclerosis (MS). Specifically, recently reported efficacy and safety data are discussed regarding the use of natalizumab, daclizumab, rituximab, and alemtuzumab in patients with MS. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, expert neurologists discuss the rationales for integrating targeted therapies into the management of multiple sclerosis (MS). Specifically, recently reported efficacy and safety data are discussed regarding the use of natalizumab, daclizumab, rituximab, and alemtuzumab in patients with MS. http://podcast.peerviewpress.com/neurology/PA03646FC1r326.mp3 http://podcast.peerviewpress.com/neurology/PA03646FC1r326.mp3 Wed, 08 Aug 2007 16:40:23 -0400 Science no 00:30:44 Alemtuzumab, B cell, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin-2 receptor, Mitoxantrone, Monoclonal antibody, Multiple sclerosis, Natalizumab, Progressive multifocal leukoencephalopathy (PML) PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03646FC1r326CMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03646FC1r326CMEinfo.pdf Wed, 08 Aug 2007 16:40:18 -0400 Science no 00:00:00 Alemtuzumab, B cell, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin-2 receptor, Mitoxantrone, Monoclonal antibody, Multiple sclerosis, Natalizumab, Progressive multifocal leukoencephalopathy (PML) PeerView Press In this activity, pain management experts discuss chronic pain therapy with prescription opioids by focusing on the enhancement of communication between the patient and healthcare professional. Specifically, tactics for facilitating communication are presented, as well as strategies for overcoming typical obstacles to successful pain management. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, pain management experts discuss chronic pain therapy with prescription opioids by focusing on the enhancement of communication between the patient and healthcare professional. Specifically, tactics for facilitating communication are presented, as well as strategies for overcoming typical obstacles to successful pain management. http://podcast.peerviewpress.com/neurology/PA03728FCs338.mp3 http://podcast.peerviewpress.com/neurology/PA03728FCs338.mp3 Tue, 22 May 2007 16:11:54 -0400 Science no 00:27:23 Pain, chronic pain, opioid, noncancer pain, methadone, codeine, fentanyl, oxycodone, hydrocodone, propoxyphene, communication, cognitive impairment, addiction, JCAHO PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03728FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03728FCCMEinfo.pdf Tue, 22 May 2007 16:10:44 -0400 Science no 00:00:00 Pain, chronic pain, opioid, noncancer pain, methadone, codeine, fentanyl, oxycodone, hydrocodone, propoxyphene, communication, cognitive impairment, addiction, JCAHO PeerView Press In this activity, experts in the treatment of Parkinson’s disease present recent data on efficacy and safety of current and emerging dopamine agonists. Effects of novel emerging delivery systems on quality of life are discussed. Evidence-based management of early Parkinson’s disease, including the recent American Academy of Neurology practice parameters, are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of Parkinson’s disease present recent data on efficacy and safety of current and emerging dopamine agonists. Effects of novel emerging delivery systems on quality of life are discussed. Evidence-based management of early Parkinson’s disease, including the recent American Academy of Neurology practice parameters, are also highlighted. http://podcast.peerviewpress.com/neurology/PA03434FCr228.mp3 http://podcast.peerviewpress.com/neurology/PA03434FCr228.mp3 Mon, 30 Oct 2006 16:11:58 -0500 Science no 00:21:07 Parkinson’s disease, dopamine agonists, levodopa, delivery systems, bromocriptine, pergolide, apomorphine, pramipexole, ropinirole, rotigotine, transdermal patch, infusion, rigidity, bradykinesia, rest tremor PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03434FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PAO3434FCCMEinfo.pdf Mon, 30 Oct 2006 16:11:35 -0500 Science no 00:00:00 Parkinson’s disease, dopamine agonists, levodopa, delivery systems, bromocriptine, pergolide, apomorphine, pramipexole, ropinirole, rotigotine, transdermal patch, infusion, rigidity, bradykinesia, rest tremor PeerView Press In this activity, experts in the diagnosis and treatment of restless legs syndrome (RLS) present the key diagnostic features of RLS and recent data on the efficacy and safety of dopamine agonists in the treatment of RLS. Criteria for diagnosis and guidelines for treatment are also discussed. The daily impact that RLS can have on patients who suffer from the condition is also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the diagnosis and treatment of restless legs syndrome (RLS) present the key diagnostic features of RLS and recent data on the efficacy and safety of dopamine agonists in the treatment of RLS. Criteria for diagnosis and guidelines for treatment are also discussed. The daily impact that RLS can have on patients who suffer from the condition is also highlighted. http://podcast.peerviewpress.com/neurology/PA03373FCinR204.mp3 http://podcast.peerviewpress.com/neurology/PA03373FCinR204.mp3 Thu, 07 Sep 2006 08:51:51 -0400 Science no 00:22:09 restless legs syndrome, RLS, ropinirole, pramipexole, dopamine agonists, levadopa, dopaminergic agents, sleep apnea, augmentation, rebound, periodic limb movements, PLMS, benzodiazepines, opioids, anticonvulsants PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03373FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03373FCCMEinfo.pdf Thu, 07 Sep 2006 08:51:13 -0400 Science no 00:00:00 restless legs syndrome, RLS, ropinirole, pramipexole, dopamine agonists, levadopa, dopaminergic agents, sleep apnea, augmentation, rebound, periodic limb movements, PLMS, benzodiazepines, opioids, anticonvulsants PeerView Press In this CME activity, experts in the treatment and prevention of stroke present recent data on the efficacy and safety of antiplatelet combinations in the prevention of recurrent stroke. Updated guidelines focusing on risk factor management and stroke prevention are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment and prevention of stroke present recent data on the efficacy and safety of antiplatelet combinations in the prevention of recurrent stroke. Updated guidelines focusing on risk factor management and stroke prevention are also highlighted. http://podcast.peerviewpress.com/neurology/PA03393FCinR194.mp3 http://podcast.peerviewpress.com/neurology/PA03393FCinR194.mp3 Thu, 10 Aug 2006 13:28:09 -0400 Science no 00:13:35 stroke, stroke prevention, clopidogrel, extended-release dipyridamole, aspirin, ESPRIT trial, CHARISMA trial, atherothrombotic, atherosclerosis, antiplatelet, antiplatelet combination therapies PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/neurology/PA03393FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA03393FCCMEinfo.pdf Thu, 10 Aug 2006 13:28:02 -0400 Science no 00:00:00 stroke, stroke prevention, clopidogrel, extended-release dipyridamole, aspirin, ESPRIT trial, CHARISMA trial, atherothrombotic, atherosclerosis, antiplatelet, antiplatelet combination therapies